Accelerated radiation treatment effective for noninvasive breast cancer

Accelerated whole breast irradiation after lumpectomy is an effective treatment for ductal carcinoma in situ (DCIS), a very common early stage and noninvasive form of breast cancer, meaning many more breast cancer patients could see their treatment times reduced by half, according to a study in the June issue of the International Journal of Radiation Oncology•Biology•Physics, the official scientific journal of the American Society for Radiation Oncology (ASTRO).

The widespread use of mammography beginning in the early 1980s has led to a dramatic increase in the number of DCIS instances detected, making this one of the most common forms of . Multiple studies have proven that lumpectomy plus radiation significantly reduces the risk of recurrence in both noninvasive and invasive breast cancers and for DCIS, the current standard of treatment is lumpectomy followed by five to six weeks of whole breast radiation.

However, for invasive cancers, the use of an accelerated form of radiation that increases the strength of the dose per treatment and uses fewer treatment sessions overall has been well-established as effective, providing patients with a shorter treatment time with similar positive results. The effectiveness of an accelerated treatment time has not been established for DCIS.

Researchers in the study followed 145 DCIS patients who were treated with lumpectomy and accelerated whole breast irradiation or with accelerated whole plus an additional daily boost. At five years post-treatment, only 4.1 percent of patients experienced a recurrence, which is comparable to the five to 10 percent recurrence rate demonstrated in randomized trials for patients receiving standard radiation.

"The results of our study suggest that DCIS patients can be safely treated with a shorter regimen of radiotherapy," Silvia Formenti, MD, senior author of the study and a radiation oncologist at New York University School of Medicine, said. "This is good news for many who would prefer to receive their treatments in a shorter period of time, but also want the peace of mind that they are receiving the most effective treatment available."

add to favorites email to friend print save as pdf

Related Stories

IMRT reduces risk of side effects in breast cancer patients

Mar 28, 2012

Breast cancer patients treated with intensity modulated radiation therapy (IMRT) instead of standard whole breast irradiation (WBI) have a lower incidence of acute or chronic toxicities, according to a study in Practical Ra ...

Recommended for you

Study suggests new approach to fight lung cancer

9 hours ago

Recent research has shown that cancer cells have a much different – and more complex – metabolism than normal cells. Now, scientists at The University of Texas at Dallas have found that exploiting these differences might ...

Study evaluates procedures for diagnosing sarcoidosis

10 hours ago

Among patients with suspected stage I/II pulmonary sarcoidosis who were undergoing confirmation of the condition via tissue sampling, the use of the procedure known as endosonographic nodal aspiration compared with bronchoscopic ...

User comments

More news stories

Getting enough sleep could help prevent type 2 diabetes

Men who lose sleep during the work week may be able to lower their risk of developing Type 2 diabetes by getting more hours of sleep, according to Los Angeles Biomedical Research Institute (LA BioMed) research findings presented ...

Aspirin may fight cancer by slowing DNA damage

Aspirin is known to lower risk for some cancers, and a new study led by a UC San Francisco scientist points to a possible explanation, with the discovery that aspirin slows the accumulation of DNA mutations in abnormal cells ...